Share Name Share Symbol Market Type Share ISIN Share Description
Summit Corporation LSE:SUMM London Ordinary Share GB00BN40HZ01 ORD 1P
  Price Change % Change Share Price Bid Price Offer Price High Price Low Price Open Price Shares Traded Last Trade
  -5.00p -2.50% 195.00p 190.00p 200.00p 200.00p 195.00p 200.00p 31,475 15:25:31
Industry Sector Turnover (m) Profit (m) EPS - Basic PE Ratio Market Cap (m)
Pharmaceuticals & Biotechnology 25.4 -10.9 -10.6 - 137.01

Summit Corp Share Discussion Threads

Showing 39601 to 39624 of 39625 messages
Chat Pages: 1585  1584  1583  1582  1581  1580  1579  1578  1577  1576  1575  1574  Older
DateSubjectAuthorDiscuss
24/5/2018
22:00
What if all the disillusioned IMM 'investors' came over here. Would anyone on this board be happy?
solomon
21/5/2018
23:20
If the 48 wk results are a success, does anyone have any thoughts as to what 'endpoint' might merit an FDA approach pre- phase 3? i.e. What grounds might an FDA approval need now that we're potentially over the necessity for 6 MWT and ambulatory info? There's a great summary here including info by Kay Davies(apologies if this has been the rounds before but it's a very informative reseumé from February) There's mention of the "mean fat fraction" presenting primary endpoint criteria but that did not present anything positive at 24 wks. Enrol here with an email address: www.tandfonline.com Then see: hTTps://www.tandfonline.com/doi/full/10.1080/21678707.2018.1438261
hugus maximus
21/5/2018
15:51
Thanks, Hugus. That's what I was hoping.
luminoso
21/5/2018
15:37
Afternoon Luminoso, Had a chat with Richard Pye a couple of weeks ago and asked if a T.O. were ever an issue, would SRPT's EU license and funding 40% DMD work prevent other potential suitors from making an approach and indeed that's not the case.
hugus maximus
21/5/2018
13:27
Thanks Hugus. It does not say much for the powers of research of the punters you describe from the nasdaq boards. Basically, those traders are pure momentum traders. If the share price is high, it must be good. If the share price is low, it must be bad ... or something does not add up. It also explains the share price of Sarepta at the moment. Of course many of these punters will be caught with their pants down, if Sarepta's share price implodes on fundamentals and Summit's share price explodes on likely approval of EZT. At some point, I expect Sarepta to make a move on EZT, either parts or the whole, as it will become increasingly clear to them that EZT is the most likely candidate around, currently, to make a difference to DMD boys. They have the cash still to achieve that but while the market sleeps with regard to EZT, they still have time before they have to make a move - around 48 week results time maybe ? The big question for me is - will they have any competition to acquire EZT the closer we get to results and, dare I say it, Approval ?
luminoso
20/5/2018
17:22
Possibly just a couple of months away from DMD P2 48 wk results and we need Summit to start broadcasting a summary of their amazing W-I-P. IMO the idea that a simple repeat of EZD 24 wks data @ 48 wks may be all that's needed to produce a Becker MD type prognosis for DMD boys, must allow the families a real sense of expectation for life changing possibilities. (i.e. Becker MD has a life expectancy of 50's and even 60's ... DMD has a life expectancy of 20's) Given that the Monaco conference was many weeks ago when Glyn mentioned this, I'm surprised that investment analysts have not even taken this fact on board in updates and it's disappointing to see the share price still hanging around £2. In the USA, an investor on a message board sums up what I would say is typical NASDAQ punters view of Summit and EZD. They are blinded by what they see as the ridiculous improbability of such a low share price hiding any sort of success:- "Something doesn't add up" EDIT: i.e.The general view is : "This can't possibly be a success, as at this stage the share price would not be so low." Of course none of this matters, unless anticipating the opportunity to de-risk a little before 48 wk RNS.
hugus maximus
20/5/2018
17:07
$14 proving a very hard nut to crack.
luminoso
18/5/2018
11:05
Not sure football share price still not settled lets see how today goes.
chrisatrdg
18/5/2018
01:09
$15 today now $14 has gone?
football
16/5/2018
22:38
A high volume rise on Nazzy. Does that actually mean anything? Better than a high volume fall. Not as good as an astronomical takeoff.
solomon
16/5/2018
11:06
Thanks Guys,suspected it might just be business as usual but wasn't sure.Thanks for the clarification.
algernon2
16/5/2018
08:14
They do shelf filings every year, gives them the option to raise if and when needed.
waterloo01
16/5/2018
08:11
from link above Subject to completion, dated May 15, 2018 $225,000,000 PROSPECTUS SUMMIT THERAPEUTICS PLC Debt Securities Ordinary Shares American Depositary Shares representing Ordinary Shares Units Warrants We may issue securities from time to time in one or more offerings of up to $225,000,000 in aggregate offering price. This prospectus describes the general terms of these securities and the general manner in which these securities will be offered. We will provide the specific terms of these securities in supplements to this prospectus. The prospectus supplements will also describe the specific manner in which these securities will be offered and may also supplement, update or amend information contained in this document. You should read this prospectus and any applicable prospectus supplement carefully before you invest. We may offer these securities in amounts, at prices and on terms determined at the time of offering. The securities may be sold directly to you, through agents, or through underwriters and dealers. If agents, underwriters or dealers are used to sell the securities, we will name them and describe their compensation in a prospectus supplement. Our ADSs are listed on The Nasdaq Global Market under the symbol “SMMT.” Our ordinary shares are admitted for trading on AIM, a market operated by the London Stock Exchange plc, or AIM, under the listing code “SUMM.”
football
16/5/2018
01:01
hTTps://www.sec.gov/Archives/edgar/data/1599298/000119312518164105/d586412df3.htm
kabo87
15/5/2018
13:28
The DMD Clinical trial finder is a brilliant resource if you are tracking research and upcoming trials for #duchenne in the UK. Clinical Trial Finder | DMD Hub hTTps://dmdhub.org/clinical-trial-finder/#.WvrDX0cEd8Q.twitter
chrisatrdg
15/5/2018
13:06
Summit Therapeutics presenting at Proactive One2One Forum this Thursday evening in London. Details and registration can be found here: https://tinyurl.com/yc8p8q62
aim_trader
14/5/2018
16:53
Thanks Freedosh ... thought you might suggest that. EDIT : Then simply a repeat of 24 wk data at 48 wks might possibly be admissible for FDA approval!
hugus maximus
14/5/2018
16:39
I guess it’s a possibility, Hugus. And a pretty good possibility at that.
freedosh
14/5/2018
13:03
In addition I came across this: hTTps://thefly.com/landingPageNews.php?id=2705462&headline=SMMT;SRPT-FDA-guidance-to-Sarepta-could-speed-Summits-DMD-path-says-JMP-Securities
hugus maximus
13/5/2018
16:28
Good afternoon Freedosh. Hope this finds you happy and health continuing to improve. Would love to know your thoughts. I wondered if recent reports have changed your opinion of earlier in the year when you suggested that potential FDA approval of EZD was still needing to see some sort of "functional stability or improvement"? I mention this in light of the following: 1. Published 3rd May 2018: hTTps://journals.lww.com/neurotodayonline/Fulltext/2018/05030/Policy_Watch__FDA_Issues_New_Clinical_Trial.6.aspx 2. Published 19th March 2018: hTTp://journals.plos.org/plosone/article?id=10.1371/journal.pone.0194283 Many thanks for any informed opinion you might proffer. On behalf of the great unwashed. Warmest regards HM
hugus maximus
12/5/2018
10:37
Closing price on NASDAQ $14 = £2.02p AIM.
hugus maximus
11/5/2018
22:01
Yes it's $1 more than $13 :-) https://www.barchart.com/stocks/quotes/SMMT/cheat-sheet
football
11/5/2018
20:29
$14 does seem to be an emotional border. edit: yesss .....$14 Does that actually mean anything?
solomon
10/5/2018
20:02
come on $14 ffs
football
Chat Pages: 1585  1584  1583  1582  1581  1580  1579  1578  1577  1576  1575  1574  Older
Your Recent History
LSE
GKP
Gulf Keyst..
LSE
QPP
Quindell
FTSE
UKX
FTSE 100
LSE
IOF
Iofina
FX
GBPUSD
UK Sterlin..
Stocks you've viewed will appear in this box, letting you easily return to quotes you've seen previously.

Register now to create your own custom streaming stock watchlist.

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

P:33 V: D:20180525 01:37:27